Multimeric IL-15 soluble fusion molecules and methods of making and using same
The present invention features compositions and methods featuring ALT-803, a complex of an interleukin-15 (IL-15) superagonist mutant and a dimeric IL-15 receptor α/Fc fusion protein useful for enhancing an immune response against a neoplasia (e.g., multiple myeloma, melanoma, lymphoma) or a viral infection (e.g., human immunodeficiency virus).
1. A nucleic acid sequence encoding an IL-15 receptor fusion polypeptide comprising an IL-15 sushi-binding domain fused to an Fc domain (IL-15RαSu/Fc), and an interleukin-15 polypeptide.
2. A DNA vector comprising the nucleic acid of claim 1 .
3. A method of making an IL-15:IL-15RαSu/Fc fusion protein complex, the method comprising:
a) introducing into a host cell a first DNA encoding an interleukin-15 (IL-15) polypeptide and a second DNA encoding an IL-15Rα/Fc fusion protein comprising an IL-15 sushi-binding domain fused to an Fc domain (IL-15RαSu/Fc);
b) culturing the host cell in media under conditions sufficient to express the IL-15 and the IL-15Rα/Fc fusion protein; and
c) purifying the IL-15:IL-15Rα/Fc complex from the host cell or media.
4. A method of making an IL-15:IL-15RαSu/Fc fusion protein complex, the method comprising:
a) co-expressing an interleukin-15 (IL-15) polypeptide and an IL-15RαSu/Fc fusion protein comprising an IL-15 sushi-binding domain fused to an Fc domain (IL-15RαSu/Fc) in a host cell;
b) culturing the host cell in media under conditions sufficient to express the IL-15 and the IL-15RαSu/Fc fusion protein; and
c) purifying the IL-15:IL-15RαSu/Fc fusion protein complex from the host cell or media wherein both IL-15 binding sites of the IL-15:IL-15RαSu/Fc complex are fully occupied.
5. A cell comprising a first polynucleotide encoding an interleukin-15 (IL-15) and a second polynucleotide encoding an IL-15 receptor fusion protein comprising an IL-15 sushi-binding domain fused to an Fe domain (IL-15RαSu/Fc).